Cite
HARVARD Citation
Stone, J. et al. (n.d.). Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?. Pharmacoepidemiology and drug safety. pp. 223-227. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stone, J. et al. (n.d.). Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?. Pharmacoepidemiology and drug safety. pp. 223-227. [Online].